Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma Proteomics Study of End-Stage Liver Disease Patients Based on Olink Technology

NCT06865898 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.

NCT NCT06865898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06865898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma Proteomics Study of End-Stage Liver Disease Patients Based on Olink Technology
Lead sponsor
Qilu Hospital of Shandong University
Phase
Observational
Overall status
Active, not recruiting
Start date
March 1, 2023
Completion date
March 31, 2025
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hbv related acute-on-chronic liver failure